Man Group plc Purchases 1,405,554 Shares of Oscar Health, Inc. (NYSE:OSCR)

Man Group plc raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 344.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,813,216 shares of the company's stock after purchasing an additional 1,405,554 shares during the quarter. Man Group plc owned approximately 0.73% of Oscar Health worth $24,370,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently modified their holdings of the company. Tower Research Capital LLC TRC boosted its position in shares of Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock valued at $89,000 after acquiring an additional 4,185 shares during the period. KBC Group NV raised its position in shares of Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after buying an additional 2,555 shares in the last quarter. Alberta Investment Management Corp purchased a new position in Oscar Health in the fourth quarter worth $138,000. Virtu Financial LLC bought a new position in Oscar Health during the fourth quarter valued at approximately $140,000. Finally, Potentia Wealth purchased a new position in shares of Oscar Health in the fourth quarter worth about $141,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Trading Down 6.5%

Shares of OSCR traded down $1.07 during trading hours on Wednesday, reaching $15.41. 5,998,304 shares of the company traded hands, compared to its average volume of 4,234,990. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79. The company's fifty day moving average price is $13.58 and its two-hundred day moving average price is $14.64. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $3.86 billion, a price-to-earnings ratio of -772.36 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.83 by $0.09. The business had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Oscar Health's quarterly revenue was up 42.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.62 earnings per share. Equities research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Oscar Health currently has a consensus rating of "Hold" and an average price target of $20.08.

Insider Buying and Selling at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director now directly owns 64,512 shares of the company's stock, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 24.39% of the stock is owned by company insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.